Results 1 - 20 of 26 in Aldara, Imiquimod (generic)
-
Conquering keloids: New therapies offer hope to patients with troublesome scars
National report - Dermatologists can treat patients with keloids more effectively due to new treatment choices, according to an expert who treats patients who have darker skin. Comment?
-
Extensive SCC: Unusual case poses challenges in delineating etiology and management
The case of a young adult patient presenting with an extensive plaque of squamous cell carcinoma is of interest because of the puzzling etiology of the malignancy and the therapeutic challenge it presented, his physicians say. Comment?
-
Graceway Pharmaceuticals Acquires Early-Stage Dermatological...
Graceway Pharmaceuticals, LLC, a portfolio company of GTCR Golder Rauner, LLC, and Pfizer Inc. Comment?
-
Graceway Pharmaceuticals Acquires Early-stage Dermatological Molecules from Pfizer
Graceway Pharmaceuticals, LLC, a portfolio company of GTCR Golder Rauner, LLC, and Pfizer Inc. Comment?
-
Human wart drug effective on horse ear lesions
Aural plaques appear as whitish lesions on the inner surface of the ear. Dr Stephen White/Merck Veterinary Manual A product has been shown to be effective in the treatment of specific ear lesions, called aural plaques, in horses. Comment?
-
Long-term AK clearance: Topical imiquimod outperforms cryotherapy, 5-FU
Las Vegas — Topical imiquimod field treatment addresses not only visible and subclinical actinic keratoses , but it also appears to provide greater long-term clearance than does liquid nitrogen cryotherapy, an expert says. Comment?
-
Potential Signals of Serious Risks/New Safety Information Identified...
The table below lists the names of products and potential signals of serious risks/new safety information that were identified for these products during the period October - December 2008 in the AERS database. Comment?
-
Aldara Cream Helps in Skin Cancers and Genital Warts
Aldara is one of the trade names of Imiquimod , a prescription medication that acts as an immune response modifier. Comment?
-
Lentigo maligna: Topical agent option for malignant melanoma
Preliminary, yet promising, outcomes in two patients suggests dual therapy involving limited surgical excision followed by topical application of imiquimod 5 percent cream may be an option to consider for treating invasive malignant melanoma surrounded by lentigo maligna in patients who refuse or are not good candidates for more extensive surgery, ... Comment?
-
Plantar warts are noncancerous skin growths on the soles of your feet caused by the human papillomavirus , which enters your body through tiny cuts and breaks in your skin. 2 comments
-
In the pipeline: Researchers look for imiquimod alternatives
Aldara cream provides a unique approach to the treatment of superficial basal cell carcinomas and actinic keratosis , reducing the necessity of invasive procedures. Comment?
-
Causes, Symptoms, Treatment, Diagnosis
In this factsheet: Diagnosing HPV Infection Your doctor will make a diagnosis of skin or genital warts based on a physical exam. Comment?
-
A skin cream that prevents cancer
I'd bet that 99 per cent of readers have never heard of the name "Actinic Keratosis" . But thousands of people have this type of skin lesion that if left untreated can develop into skin cancer over time. Comment?
-
Deal with scaly patches before you develop cancer
I'd bet that 99 per cent of readers have never heard of actinic keratosis . But thousands of people have this type of skin lesion that if left untreated can develop into skin cancer over time. Comment?
-
Common warts are caused by a virus known as human papilloma virus . There are about 100 different strains of HPV. Comment?
-
Each year, more than a million Americans develop the most common type of cancer -- Basal Cell Carcinoma. Comment?
-
Each year, more than a million Americans develop the most common type of cancer -- basal cell carcinoma. Comment?
-
Each year, more than a million Americans develop the most common type of cancer - Basal Cell Carcinoma. Comment?
-
Imiquimod for sBCC: Five-year trial shows efficacy, cosmesis
w/Photo
A recent trial has shown that daily treatment with Aldara achieves high sustained clearance rates for superficial basal cell carcinoma five years after treatment, along with cosmetic improvements over other ... Comment?
-
Better outcomes: Topical agents may enhance surgical results
w/Photo
Combining treatments often leads to better surgical outcomes, according to James Spencer, M.D., associate professor of clinical dermatology at Mount Sinai Medical Center in New York. Comment?





